Sanofi Pasteur's dengue vaccine Dengvaxia will have to undergo phase 4 testing in Malaysia.
Takeda’s IBD Superheroes ad is pharma’s North Carolina Tarheels, winning the championship in our first DTC advertising tournament.
In what could be a direct rebuttal to President Donald Trump’s view on foreign trade, Eli Lilly CEO David Ricks called any promotion of deglobalization “…
Mylan and Biocon today won a court ruling that said they may sell their Herceptin biosimilar in India where it was first introduced three years ago.
India’s largest drugmakers want the U.S. to import their drugs to hold down healthcare costs. But questions on manufacturing quality are clouding their efforts.
Novartis is still facing fallout from last year’s kickbacks case in South Korea. Officials there levied a set of punishments and are weighing "tougher…
Masking depression is never a good idea. Otsuka and Lundbeck are back on the air to make that case with a new TV ad for antipsychotic Rexulti.
China has updated its list of medicines covered by national medical insurance, adding some new drugs in pediatrics and major illnesses such as cancer and…
Welcome to the price-pledge club, Takeda. The Japanese drugmaker has said it plans to keep its price increases in the single digits.
Takeda says its new oral multiple myeloma drug Ninlaro is on course to become its biggest-ever cancer product.